OCULAR HYPERTENSION TREATMENT STUDY (OHTS)

眼压过高治疗研究 (OHTS)

• 批准号: 6342625
• 负责人: George A Cioffi
• 金额: $ 16.99万
• 依托单位: LEGACY EMANUEL HOSPITAL AND HEALTH CENTER
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-01-01 至 2003-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6342625
• 关键词: African American; beta antiadrenergic agent; carbachol; chemoprevention; clinical trials; cooperative study; disease /disorder proneness /risk; dosage; drug administration routes; drug adverse effect; early diagnosis; epinephrine; eye disorder chemotherapy; eye fundus photography; eye pharmacology; glaucoma; glaucoma test; human subject; human therapy evaluation; intraocular pressure; longitudinal human study; mass screening; medical complication; miotic; optic disk; pilocarpine; prognosis; statistics /biometry; therapy compliance; vision disorders; visual fields

This is an application to become a participating Clinical Center in the Ocular Hypertension treatment Study (OHTS). The complete details of the OHTS rationale, design, and methods are contained in the OHTS Manual of Procedures. This proposal provides complete documentation of the ability of Devers Eye Institute, in conjunction with Oregon Medical Eye Clinic and Oregon Eye Care, to screen large numbers of ocular hypertensive patients and to enroll at least 50 eligible patients over a 24-month period. Documentation is provided of the capabilities of the proposed investigators and their staff for the performance of the study in accord with the details of the OHTS Manual of Procedures, the nature and extent of their commitment to Devers Eye Institute, and a list of two organizations/sixteen practitioners in the area who will refer patients screened for enrollment and randomization to treatment in the OHTS clinical trial.

这是成为参与临床中心的应用 眼高血压治疗研究（OHTS）。 完整的细节 OHTS理由，设计和方法包含在OHTS手册中 程序。 该建议提供了Devers Eye能力的完整文档 研究所与俄勒冈州医学眼诊所和俄勒冈州的眼睛结合 护理，筛查大量眼部高血压患者并注册 在24个月内，至少有50名合格的患者。 提供了拟议调查员的功能的文件 以及他们的员工在研究表演的情况下符合详细信息 OHTS手册，其承诺的性质和程度 去看眼科研究所，以及两个组织的名单/16个 该地区的从业人员将推荐筛查的患者入学 在OHTS临床试验中随机治疗。